loading

Anebulo Pharmaceuticals Inc (ANEB) 財務データ

損益計算書
四半期ごと
*すべての数値は百万単位です
期間終了日 2025-03-31 2024-12-31 2024-09-30 2024-03-31 2023-12-31
期間の長さ 3 か月 3 か月 3 か月 3 か月 3 か月
Revenues
-
- - - -
Operating Expenses
26.89%
1.8923
2.5882 2.4121 1.6643 2.7605
Interest Income/Expense
0.10
- - - -
Operating Income/Loss
26.89%
-1.8923
-2.5882 -2.4121 -1.6643 -2.7605
Nonoperating Income/Loss
72.76%
0.2162
0.1251 0.2114 0.0107 0.0431
Income/Loss From Continuing Operations Before Tax
31.95%
-1.6762
-2.463 -2.2007 -1.6535 -2.7174
Income/Loss From Continuing Operations After Tax
31.95%
-1.6762
-2.463 -2.2007 -1.6535 -2.7174
Net Income/Loss
31.95%
-1.6762
-2.463 -2.2007 -1.6535 -2.7174
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
49.86%
41.08
27.42 25.93 25.93 25.79
Diluted Average Shares
49.86%
41.08
27.42 25.93 25.93 25.79
Basic Earnings Per Share
55.56%
-0.04
-0.09 -0.08 -0.06 -0.11
Diluted Earnings Per Share
55.56%
-0.04
-0.09 -0.08 -0.06 -0.11
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$85.44
price down icon 1.75%
$27.38
price up icon 1.11%
$23.80
price up icon 1.19%
$103.50
price up icon 3.07%
$142.53
price down icon 0.68%
biotechnology ONC
$318.73
price down icon 5.21%
大文字化:     |  ボリューム (24 時間):